Pages that link to "Q33591747"

The following pages link to Pim1 promotes human prostate cancer cell tumorigenicity and c-MYC transcriptional activity (Q33591747):

Displaying 40 items.

• Pim-1 kinase as cancer drug target: An update (Q28273475) (← links)
• Conditional transgenic expression of PIM1 kinase in prostate induces inflammation-dependent neoplasia (Q28485913) (← links)
• The role of PIM1/PIM2 kinases in tumors of the male reproductive system (Q28818309) (← links)
• RANK-mediated signaling network and cancer metastasis. (Q30371052) (← links)
• RNAi screen identifies a synthetic lethal interaction between PIM1 overexpression and PLK1 inhibition (Q33861057) (← links)
• Cell and gene therapy for severe heart failure patients: the time and place for Pim-1 kinase (Q34075071) (← links)
• ERG deregulation induces PIM1 over-expression and aneuploidy in prostate epithelial cells (Q34091302) (← links)
• Evaluation of the antitumor effects of c-Myc-Max heterodimerization inhibitor 100258-F4 in ovarian cancer cells (Q34161727) (← links)
• Dual role of FoxA1 in androgen receptor binding to chromatin, androgen signalling and prostate cancer (Q34216102) (← links)
• Pim-1 acts as an oncogene in human salivary gland adenoid cystic carcinoma (Q35005230) (← links)
• PIM kinase inhibitor AZD1208 for treatment of MYC-driven prostate cancer (Q35078578) (← links)
• Troglitazone suppresses c-Myc levels in human prostate cancer cells via a PPARγ-independent mechanism (Q35124419) (← links)
• Pim1 kinase is required to maintain tumorigenicity in MYC-expressing prostate cancer cells (Q35571648) (← links)
• RAMP1 is a direct NKX3.1 target gene up-regulated in prostate cancer that promotes tumorigenesis (Q37149065) (← links)
• PIM1 kinase inhibition as a targeted therapy against triple-negative breast tumors with elevated MYC expression (Q37686796) (← links)
• Why Target PIM1 for Cancer Diagnosis and Treatment? (Q37797472) (← links)
• The PIM family of serine/threonine kinases in cancer (Q38098139) (← links)
• Pim kinases in hematological malignancies: where are we now and where are we going? (Q38285805) (← links)
• Targeting neuroendocrine prostate cancer: molecular and clinical perspectives (Q38362686) (← links)
• PIM kinase (and Akt) biology and signaling in tumors. (Q38370023) (← links)
• Biochemical changes of salivary gland adenoid cystic carcinoma cells induced by SGI-1776. (Q38715353) (← links)
• PIM1 kinase as a promise of targeted therapy in prostate cancer stem cells (Q38719202) (← links)
• PIM1 gene silencing inhibits proliferation and promotes apoptosis of human esophageal cancer cell line Eca-109. (Q38725923) (← links)
• Loss of PIM2 enhances the anti-proliferative effect of the pan-PIM kinase inhibitor AZD1208 in non-Hodgkin lymphomas. (Q38813901) (← links)
• Regulation of prostate stromal fibroblasts by the PIM1 protein kinase. (Q38934636) (← links)
• A combination strategy to inhibit Pim-1: synergism between noncompetitive and ATP-competitive inhibitors. (Q39189299) (← links)
• Phosphorylation of the androgen receptor by PIM1 in hormone refractory prostate cancer (Q39276825) (← links)
• MYC-Master Regulator of the Cancer Epigenome and Transcriptome (Q39306981) (← links)
• HistoneH3 demethylase JMJD2A promotes growth of liver cancer cells through up-regulating miR372. (Q41472320) (← links)
• Targeting MYC sensitizes malignant mesothelioma cells to PAK blockage-induced cytotoxicity (Q41547630) (← links)
• Inflammation and stem markers association to PIM1/PIM2 kinase-induced tumors in breast and uterus. (Q41708939) (← links)
• LAMC2 as a therapeutic target for cancers (Q42461453) (← links)
• MYC and Prostate Cancer (Q42731671) (← links)
• Expression of PIM-1 in salivary gland adenoid cystic carcinoma: Association with tumor progression and patients' prognosis (Q49225961) (← links)
• Loss of PIM1 correlates with progression and prognosis of salivary adenoid cystic carcinoma (SACC). (Q50295611) (← links)
• Time-Dependent Effects of POT1 Knockdown on Proliferation, Tumorigenicity, and HDACi Response of SK-OV3 Ovarian Cancer Cells. (Q54254952) (← links)
• Pim1 supports human colorectal cancer growth during glucose deprivation by enhancing the Warburg effect. (Q54982371) (← links)
• Pim1 promotes cell proliferation and regulates glycolysis via interaction with MYC in ovarian cancer (Q57817294) (← links)
• PIM kinase inhibition: co-targeted therapeutic approaches in prostate cancer (Q89559314) (← links)
• PIM protein kinases regulate the level of the long noncoding RNA H19 to control stem cell gene transcription and modulate tumor growth (Q90134901) (← links)